Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
VC

VCYT

Market Closed

Veracyte, Inc.

NASDAQHealthcareMedical - Diagnostics & Research
US
755 employees
CEO: Marc Stapley
Founded: 2013
$24.33
+$0.00(+NaN%)
Market Cap
1.96B
Beta
1.96
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Veracyte's current price trades 51.2% below the PERT-weighted fair value, indicating potential undervaluation. However, Monte Carlo analysis shows significant downside risk (66.7%) with expected value near current price, reflecting growth and profitability challenges amid strong liquidity and leverage metrics. Valuation disparity highlights uncertainty in future performance.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore VCYT

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

VCYT in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Medical - Diagnostics & Research

Browse industry stocks →